ASX200 Healthcare & Tech Update: Why SHL and XRO Shares Are Drawing Interest in 2025

June 27, 2025 12:48 PM AEST | By Team Kalkine Media
 ASX200 Healthcare & Tech Update: Why SHL and XRO Shares Are Drawing Interest in 2025
Image source: Shutterstock

Highlights

  • SHL and XRO stocks trading below 5-year average price-to-sales ratios
  • SHL continues expansion in diagnostic healthcare services
  • XRO’s global cloud accounting footprint supports millions of users

Sonic Healthcare Ltd (SHL) and Xero Ltd (XRO) are two notable names on the ASX, attracting attention amid recent price movements and valuation shifts. Investors tracking the ASX 200 landscape may already be familiar with these companies, both included in the ASX200 index due to their market capitalisation and significance within their respective sectors.

Sonic Healthcare Ltd (ASX:SHL) Share Trends in 2025

Since the beginning of 2025, shares of Sonic Healthcare have dipped around 1.9%. Founded in 1987, the company has evolved into one of the largest global pathology and diagnostic service providers. Its operations span Australia, New Zealand, Europe, and North America.

The business delivers a diverse suite of medical services, including pathology, diagnostic imaging, radiology, general practice, and corporate healthcare solutions. With a focus on medical excellence and long-term partnerships with medical professionals, SHL aims to provide sustainable, patient-centric care through advanced diagnostics.

When it comes to valuation, SHL shares currently trade at a price-to-sales (P/S) ratio of 1.44x. This is noticeably below the company’s 5-year average of 1.94x. While such a metric on its own doesn’t tell the full story, it suggests a valuation below historical norms. This may reflect either a price decline, an uptick in revenue, or a combination of both. Notably, Sonic Healthcare has maintained revenue growth over the last three years, adding weight to the potential undervaluation narrative.

Xero Ltd (ASX:XRO) Making Digital Accounting Global

On the other hand, Xero shares have demonstrated resilience in 2025, trading 45.3% above their 52-week low. Founded in New Zealand in 2006, Xero has emerged as a global leader in cloud-based accounting platforms. Its software ecosystem is widely used across New Zealand, Australia, the UK, and gradually expanding in the US.

Xero’s offerings enable accountants and bookkeepers to better support small businesses with real-time data access and financial insights available across devices. With over 3,000 employees and millions of users worldwide, the company continues scaling operations while maintaining its design-forward approach to financial tools.

Currently, the XRO share price reflects a P/S ratio of 18.06x, which is slightly lower than its 5-year average of 18.65x. This suggests that, like SHL, XRO may be trading below its historical valuation multiple, even after significant recent gains.

Both Sonic Healthcare and Xero present unique sectoral strengths—healthcare diagnostics and digital finance—and their relative valuations in 2025 suggest renewed attention from those monitoring ASX 200 constituents.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.